Skip to main content
Caleb Ho, MD, Pathology, New York, NY, Memorial Sloan Kettering Cancer Center

CalebHoMD

Pathology New York, NY

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant Attending, Hematopathology and Diagnostic Molecular Pathology

Dr. Ho is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ho's full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Molecular Genetic Pathology, 2015 - 2016
  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Hematopathology, 2014 - 2015
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 2010 - 2014
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2008

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2016 - 2025
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • MA State Medical License
    MA State Medical License 2014 - 2024
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Pathology - Hematology
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Abstracts/Posters

  • Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase
    Caleb Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
    Caleb Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
    Caleb Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a Spike-in Clonal Sequence 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • MRD-Response Driven Phase I/II Study for Newly Diagnosed Multiple Myeloma Patients Using Higher Doses of Twice-Weekly Carfilzomib (45 and 56 mg/m2) in Combination with... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Other Languages

  • Chinese (Cantonese)

Hospital Affiliations